title: [Chapter 5. The internationalization of the Japanese pharmaceutical industry (1980-2010)].
abstract: The Japanese pharmaceutical industry experienced a period of rapid and economic growth following the introduction of the national healthcare system in 1961. Triggered by a major revision in Japanese legislation from process to substance patents, leading Japanese pharmaceutical companies began to invest in research and development (R&D). By the mid-1980s, some had managed to develop their first internationally marketable drugs, many of which were antibiotics. The emergence of novel drugs gave companies the impetus to engage in progressively more appreciable investments in Asia, Europe and the United States. In the 1980s, internationalization was mainly inwardly focused so as to limit firms' exposure to risk. However, as profits increased in the 1990s from the sale of new drugs, Japanese pharmaceutical companies were able to engage in even more sizeable, outwardly focused investments. By 2010, Japan's leading pharmaceutical enterprises had succeeded in putting place three types of global operations: manufacturing, marketing and R&D.
authors.forename: Julia S
authors.initials: JS
authors.lastname: Yongue
mesh_terms: D003132:Commerce; D004345:Drug Industry / Q000266:history*; D049673:History, 20th Century; D049674:History, 21st Century; D038622:Internationality; D007449:Investments; D007564:Japan